학술논문
The Novel BCR::ABL1 Allosteric Inhibitor HS-10382/TERN-701 is Potent Against Mutations Resistant to Active Site Tyrosine Kinase Inhibitors (TKIs) and Acts Synergistically With TKIs in BCR::ABL1+Cancer Cell Lines
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
21522669